06:02:57 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



T:GUD - KNIGHT THERAPEUTICS INC. - https://www.gud-knight.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GUD - T  0.35.86·5.983.05.88+0.040.7230.31,3382795.85  5.92  5.856.55  5.4216:16:16Dec 1815 min RT 2¢
TSX - T0.35.86·5.983.05.88+0.040.755.13151365.85  5.92  5.856.55  5.4216:16:1615 min
NEO ATS - U 5.89+0.050.989.2525185.89  5.89  5.8815:52:0515 min
Alpha - A 5.89+0.050.93.62155.86  5.89  5.8615:59:5015 min
Omega - O 5.88+0.040.71.16115.88  5.89  5.8715:52:5115 min
CSE ATS - P 5.88+0.040.74.325105.87  5.89  5.8715:55:5715 min
CXC - X 5.88+0.040.72.513165.87  5.90  5.8715:59:5215 min
CXD - D 5.88+0.040.75.229175.875  5.89  5.87515:59:5115 min
LiquidNet - L 5.905+0.0651.150.029515.905  5.905  5.90509:30:1315 min
MatchNOW - M 5.8417.910256    Sep 11-2015 min
Lynx - Y 5.87+0.030.51.4875.89  5.89  5.8715:41:5815 min
CS2 - S 5.840.0502    Nov 2115 min

Recent Trades - Last 10 of 279
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:16:16T5.880.048,7009 BMO Nesbitt9 BMO NesbittKX
16:00:00T5.880.0410053 Morgan Stanley79 CIBCKQ
16:00:00T5.880.041001 Anonymous39 Merrill LynchKQ
15:59:55M5.890.05561 Anonymous2 RBCE
15:59:55T5.890.051001 Anonymous2 RBCK
15:59:53M5.890.052379 CIBC79 CIBCE
15:59:52M5.890.05771 Anonymous2 RBCE
15:59:52X5.880.041002 RBC39 Merrill LynchK
15:59:51D5.880.042002 RBC2 RBCK
15:59:51M5.890.05671 Anonymous2 RBCE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-12-18 17:20C:GUD6.04News ReleaseKnight Therapeutics gets Health Canada OK for Wynzora
2025-11-06 07:58C:GUD5.84SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-06 07:58C:GUD5.84SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-06 07:30C:GUD5.84News ReleaseKnight Therapeutics Reports Third Quarter 2025 Results
2025-10-31 19:24C:GUD5.84News ReleaseKnight Therapeutics closes revolving credit facility
2025-10-30 17:15C:GUD5.80News ReleaseKnight Therapeutics Announces Launch of JORNAY PM(TM) in Canada
2025-10-30 16:31C:GUD5.80News ReleaseKnight Therapeutics to release Q3 2025 results Nov. 6
2025-10-30 16:23C:GUD5.80News ReleaseKnight launches Minjuvi in Argentina for DLBCL patients
2025-10-07 17:04C:GUD5.85News ReleaseKnight Therapeutics relaunches Orgovyx in Canada
2025-10-07 17:01C:GUD5.85News ReleaseKnight Therapeutics relaunches Myfembree in Canada
2025-08-20 16:11C:GUD6.39News ReleaseKnight Therapeutics receives TSX approval for NCIB
2025-08-07 07:50C:GUD6.29SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-07 07:50C:GUD6.29SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-07 07:30C:GUD6.29News ReleaseKnight Therapeutics Reports Second Quarter 2025 Results
2025-08-05 17:57C:GUD6.27News ReleaseKnight submits Crexont Parkinson's drug in Mexico
2025-08-04 16:30C:GUD6.17News ReleaseKnight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America
2025-08-01 16:52C:GUD6.17News ReleaseKnight Therapeutics to release Q2 results Aug. 7
2025-07-31 20:52C:GUD6.09News ReleaseKnight submits supplemental application for Minjuvi
2025-07-18 10:30C:GUD6.21News ReleaseKnight files new drug submission for Crexont in Canada
2025-06-17 18:44C:GUD6.07News ReleaseKnight Therapeutics closes Paladin acquisition